XML 25 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
MedTech Acquisition Corp
Class B Common Stock
Common stock
MedTech Acquisition Corp
Additional Paid-in Capital
MedTech Acquisition Corp
Accumulated Deficit
MedTech Acquisition Corp
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2020 $ 625   $ (21,485,011) $ (21,484,386)    
Balance at the beginning (in shares) at Dec. 31, 2020 6,250,000          
Increase (Decrease) in Stockholders' Equity            
Net loss available to common stockholders     4,767,283 4,767,283 $ (28,845,000) $ (28,845,000)
Balance at the ending at Dec. 31, 2021 $ 625   (16,717,728) (16,717,103)    
Balance at the ending (in shares) at Dec. 31, 2021 6,250,000          
Increase (Decrease) in Stockholders' Equity            
Investment pursuant to business combination agreement   $ 82,741   82,741    
Accretion of shares of Class A common stock to redemption amount   $ (82,741) (2,088,562) (2,171,303)    
Net loss available to common stockholders     5,539,079 5,539,079 $ (47,187,000) $ (47,187,000)
Balance at the ending at Dec. 31, 2022 $ 625   $ (13,267,211) $ (13,266,586)    
Balance at the ending (in shares) at Dec. 31, 2022 6,250,000